FEATURED

5-Year Survival in Breast Cancer

Researchers question the meaning of 5-year survival and stress the importance of context in discussing survivorship related to breast cancer.

Drug Showcase: IBRANCE (palbociclib)

Indicated for metastatic breast cancer.

Possible Urine Test for RCC

Research indicates that a test of AQP1 and PLIN2 levels in urine may act as an indicator of early stage RCC.

Platelet Transfusion for Pts. with Cancer

Platelet transfusion can often be a vital aspect aspect of managing cancer, as treatment courses can weaken the function required to stop bleeding.

Vitamin D and Prostate Cancer

A presentation from the 249th ACS Meeting highlights the potential importance of vitamin D levels for patients with prostate cancer.

t(11;14) Translocation and Bortezomib

The t(11;14) translocation was associated with poorer response rates and shorter overall survival in patients treated with bortezomib-based regimens.

Breast Cancer in Trans Persons

A conversation with George R. Brown, MD, DFAPA, to discuss the recent reporting of 10 additional cases of breast cancer among transgendered persons.

ASCO: Outlook for U.S. Cancer Care

Representatives from ASCO held a Congressional briefing to detail their new report's findings.

RSI-MRI May Aid PCa Detection

While larger studies are needed to confirm initial findings, researchers have shown that RSI-MRI may aid physicians in detecting prostate cancer.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

Urine Test for Kidney Cancer Showing Promise

Urine Test for Kidney Cancer Showing Promise

Research indicates that a test of AQP1 and PLIN2 levels in urine may act as an indicator of early stage renal cell carcinoma (RCC).

Genetic Aberration Affects Response to Bortezomib in AL Amyloidosis

Genetic Aberration Affects Response to Bortezomib in AL Amyloidosis

The t(11;14) translocation was associated with poorer response rates and shorter overall survival in patients treated with bortezomib-based regimens.

Feature Articles

What Does '5-Year Survival' in Breast Cancer Really Mean?

What Does '5-Year Survival' in Breast Cancer Really Mean?

Researchers question the meaning of 5-year survival and stress the importance of context in discussing survivorship related to breast cancer.

Platelet Transfusion for Patients with Cancer

Platelet Transfusion for Patients with Cancer

[Cancer Control] Platelet transfusion can often be a vital aspect aspect of managing cancer, as treatment courses can weaken the function of the cells requires to stop bleeding.

Featured Videos

March/April Digital Issue

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs